BioTime (BTX) CEO Dr. Michael West to Present at University of Southern California Minisymposium: Musculoskeletal Development and Repair
5/20/2013 7:16:11 AM
More...
|
BioTime (BTX) Appoints Franklin Berger to Board of Directors
5/15/2013 7:51:08 AM
More...
|
BioTime (BTX)’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.5 Million Grant from Israel’s Office of the Chief Scientist
5/13/2013 10:07:01 AM
More...
|
BioTime (BTX) Announces First Quarter 2013 Financial Results and Recent Corporate Accomplishments
5/13/2013 7:14:05 AM
More...
|
BioTime (BTX) and Subsidiary LifeMap Sciences Announce Release of Enhanced LifeMap BioReagents™ Portal Offering Additional PureStem™ Human Progenitor Cells Including Those for Diabetes Research
5/7/2013 10:48:09 AM
More...
|
BioTime (BTX) Enters Into Worldwide License Agreement With University of California, Los Angeles (UCLA) to Develop Therapy for the Treatment of Stroke
4/19/2013 9:50:12 AM
More...
|
BioTime (BTX) Announces Fourth Quarter and Fiscal Year End 2012 Financial Results and Recent Corporate Accomplishments
3/19/2013 6:53:26 AM
More...
|
BioTime (BTX) to Present at 25th Annual ROTH Conference
3/13/2013 7:24:39 AM
More...
|
BioTime (BTX) Appoints Stephen C. Farrell to Board of Directors
3/12/2013 7:39:30 AM
More...
|
BioTime (BTX) and Subsidiary LifeMap Sciences Announce Data Mining Collaboration
3/4/2013 9:55:05 AM
More...
|
|